Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes
- PMID: 20558146
- DOI: 10.1016/j.brainres.2010.06.011
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes
Abstract
Alzheimer's disease (AD) is characterized by distinct behavioral and cognitive deficits that differ from those observed in normal aging. Transgenic models of AD are a promising tool in understanding the underlying mechanisms and cause of disease. The triple-transgenic mouse model of AD (3xTg-AD) is the only model to exhibit both Abeta and tau pathology that is characteristic of the human form. The present study characterized the performance of 3xTg-AD mice on several tasks measuring behavioral and cognitive ability. Aged 3xTg-AD females exhibited a higher level of fear and anxiety demonstrated by increased restlessness, startle responses, and freezing behaviors. No differences were observed in muscle strength and visuo-motor coordination. Understanding the behavioral manifestations that occur in this model of AD may aid in the early diagnosis and appropriate treatment of AD symptomology.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.Brain Res. 2010 Aug 12;1348:139-48. doi: 10.1016/j.brainres.2010.05.013. Epub 2010 May 31. Brain Res. 2010. PMID: 20471965
-
Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.J Alzheimers Dis. 2011;24(3):421-54. doi: 10.3233/JAD-2011-101635. J Alzheimers Dis. 2011. PMID: 21297257
-
Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.J Neurosci Res. 2004 May 15;76(4):572-80. doi: 10.1002/jnr.20127. J Neurosci Res. 2004. PMID: 15114629
-
Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.Genes Brain Behav. 2005 Apr;4(3):173-96. doi: 10.1111/j.1601-183X.2005.00124.x. Genes Brain Behav. 2005. PMID: 15810905 Review.
-
Caffeine and coffee as therapeutics against Alzheimer's disease.J Alzheimers Dis. 2010;20 Suppl 1:S117-26. doi: 10.3233/JAD-2010-091249. J Alzheimers Dis. 2010. PMID: 20182037 Review.
Cited by
-
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer's Disease.Int J Mol Sci. 2023 Mar 1;24(5):4736. doi: 10.3390/ijms24054736. Int J Mol Sci. 2023. PMID: 36902178 Free PMC article. Review.
-
Assessing Sex-Specific Circadian, Metabolic, and Cognitive Phenotypes in the AβPP/PS1 and APPNL-F/NL-F Models of Alzheimer's Disease.J Alzheimers Dis. 2022;85(3):1077-1093. doi: 10.3233/JAD-210629. J Alzheimers Dis. 2022. PMID: 34897085 Free PMC article.
-
An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.PLoS One. 2013 Aug 16;8(8):e70740. doi: 10.1371/journal.pone.0070740. eCollection 2013. PLoS One. 2013. PMID: 23976955 Free PMC article.
-
Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer's disease.Cogn Affect Behav Neurosci. 2014 Sep;14(3):996-1008. doi: 10.3758/s13415-014-0253-3. Cogn Affect Behav Neurosci. 2014. PMID: 24492993
-
Normative mice retinal thickness: 16-month longitudinal characterization of wild-type mice and changes in a model of Alzheimer's disease.Front Aging Neurosci. 2023 Apr 6;15:1161847. doi: 10.3389/fnagi.2023.1161847. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37091517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases